Yung-Jue Bang

Title: Yung-Jue Bang: Innovator in Cancer Therapy

Introduction

Yung-Jue Bang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer therapy through his innovative patents. With a total of 4 patents, his work focuses on improving treatment methods for patients suffering from cancer.

Latest Patents

One of his latest patents is titled "Quantifying Her2 protein for optimal cancer therapy." This invention provides improved methods of treatment for cancer patients by identifying whether a tumor will respond to anti-Her2 therapeutic agents. The method involves quantifying a specific Her2 fragment peptide using SRM-mass spectrometry directly in tumor cells collected from patients. This quantification is compared to a reference level to determine the likelihood of a positive response to treatment.

Another notable patent is "2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors." This invention describes a compound that is useful in treating renal, liver, or pulmonary fibrosis. The compound's formula includes specific components that enhance its therapeutic efficacy.

Career Highlights

Yung-Jue Bang has had a distinguished career, contributing to advancements in medical research and treatment methodologies. His innovative approaches have garnered attention in the scientific community, particularly in the realm of cancer therapy.

Collaborations

Throughout his career, he has collaborated with various professionals, including Hun-Taek Kim and Dae-Kee Kim. He has also worked with reputable organizations such as SK Chemicals Co., Ltd. and Ewha University-Industry Collaboration Foundation.

Conclusion

Yung-Jue Bang's contributions to cancer therapy through his patents highlight his role as a leading inventor in the field. His innovative methods and collaborations continue to pave the way for advancements in medical treatment.